Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 13  •  04:00PM ET
33.44
Dollar change
-0.19
Percentage change
-0.56
%
Category
Global or ExUS Equities - Industry Sector
Asset Type
Equities (Stocks)
Tags
Return% 1Y
28.13%
Total Holdings
60
Perf Week
-2.55%
Sponsor
Exchange Traded Concepts
ETF Type
Tags
Return% 3Y
3.77%
AUM
53.94M
Perf Month
-2.17%
Fund Family
Bond Type
Tags
Return% 5Y
-5.40%
NAV/sh
Perf Quarter
-5.12%
Index
ROBO Global Healthcare Technology & Inno...
Average Maturity
Tags
Return% 10Y
52W High
38.50 -13.14%
Perf Half Y
0.39%
Index Weighting
Commodity Type
Tags
Return% SI
52W Low
26.12 28.03%
Perf YTD
-5.32%
Active/Passive
Quant Type
Tags
-
Flows% 1M
3.09%
Volatility
1.28% 1.34%
Perf Year
22.24%
ESG Type
Tags
-
Flows% 3M
6.46%
ATR (14)
0.57
Perf 3Y
12.91%
Dividend Type
Sector/Theme
Flows% YTD
6.46%
RSI (14)
48.53
Perf 5Y
-20.85%
Structure Type
Region
Flows% 1Y
Beta
1.07
Perf 10Y
-
Expense
0.68%
Growth/Value
SMA20
-0.76%
Flows% 3Y
Rel Volume
0.25
Prev Close
33.63
Inverse/Leveraged
Market Cap
SMA50
0.15%
Flows% 5Y
Avg Volume
8.46K
Price
33.44
IPO
Jun 25, 2019
Option/Short
Yes / Yes
SMA200
-0.01%
Trades
Volume
2,096
Change
-0.56%
Jan-22-26 12:42PM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-23-25 05:45AM
Apr-18-25 01:40PM
08:30AM Loading…
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-29-25 12:50AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Oct-09-20 12:11PM
Jun-30-20 12:23PM
Jan-07-20 11:50AM
Dec-23-19 12:00PM
06:52PM Loading…
Sep-27-19 06:52PM
Sep-23-19 05:03PM
Sep-11-19 05:23PM
Aug-05-19 12:00PM
Robo Global Healthcare Technology and Innovation ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies' products and services. It is non-diversified.